Operating Margin in % of NovoCure Ltd from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
NovoCure Ltd quarterly/annual Operating Margin history and change rate from 2016 to Q3 2025.
  • NovoCure Ltd Operating Margin for the quarter ending 30 Sep 2025 was -27 %, a 0.04% decline year-over-year.
  • NovoCure Ltd annual Operating Margin for 2024 was -28 %, a 38.4% increase from 2023.
  • NovoCure Ltd annual Operating Margin for 2023 was -45 %, a 175% decline from 2022.
  • NovoCure Ltd annual Operating Margin for 2022 was -16 %, a 101% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

NovoCure Ltd Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -27 -0 -0.04% 01 Jul 2025 30 Sep 2025
Q2 2025 -27 +6 +18.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -26 +14 +34.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -28 +18 +38.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -27 +17 +38.2% 01 Jul 2024 30 Sep 2024
Q2 2024 -33 +4 +10.3% 01 Apr 2024 30 Jun 2024
Q1 2024 -40 -12 -42.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -45 -29 -1.7% 01 Oct 2023 31 Dec 2023
Q3 2023 -44 -32 -2.4% 01 Jul 2023 30 Sep 2023
Q2 2023 -37 -28 -2.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -28 -20 -2.4% 01 Jan 2023 31 Mar 2023
Q4 2022 -16 -8 -1% 01 Oct 2022 31 Dec 2022
Q3 2022 -12 -11 -7% 01 Jul 2022 30 Sep 2022
Q2 2022 -9 -13 -4.7% 01 Apr 2022 30 Jun 2022
Q1 2022 -8 -15 -2.3% 01 Jan 2022 31 Mar 2022
Q4 2021 -8 -14 -2.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -1 -6 -1.4% 01 Jul 2021 30 Sep 2021
Q2 2021 2 +1 +51.6% 01 Apr 2021 30 Jun 2021
Q1 2021 6 +6 +12.3% 01 Jan 2021 31 Mar 2021
Q4 2020 6 +6 01 Oct 2020 31 Dec 2020
Q3 2020 4 +7 01 Jul 2020 30 Sep 2020
Q2 2020 1 +8 01 Apr 2020 30 Jun 2020
Q1 2020 0 +11 01 Jan 2020 31 Mar 2020
Q4 2019 0 +13 +98.1% 01 Oct 2019 31 Dec 2019
Q3 2019 -3 +10 +76.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -6 +7 +53.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -10 +10 +49.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -13 +9 +38.9% 01 Oct 2018 31 Dec 2018
Q3 2018 -12 +22 +62.9% 01 Jul 2018 30 Sep 2018
Q2 2018 -13 +46 +76.8% 01 Apr 2018 30 Jun 2018
Q1 2018 -19 +73 +78.5% 01 Jan 2018 31 Mar 2018
Q4 2017 -22 +117 +84% 01 Oct 2017 31 Dec 2017
Q3 2017 -34 01 Jul 2017 30 Sep 2017
Q2 2017 -59 01 Apr 2017 30 Jun 2017
Q1 2017 -92 01 Jan 2017 31 Mar 2017
Q4 2016 -139 01 Oct 2016 31 Dec 2016

NovoCure Ltd Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -28 +18 +38.4% 01 Jan 2024 31 Dec 2024
2023 -45 -29 -1.7% 01 Jan 2023 31 Dec 2023
2022 -16 -8 -1% 01 Jan 2022 31 Dec 2022
2021 -8 -14 -2.3% 01 Jan 2021 31 Dec 2021
2020 6 +6 01 Jan 2020 31 Dec 2020
2019 0 +13 +98.1% 01 Jan 2019 31 Dec 2019
2018 -13 +9 +38.9% 01 Jan 2018 31 Dec 2018
2017 -22 +117 +84% 01 Jan 2017 31 Dec 2017
2016 -139 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.